Altitude Crest Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-114,042
Closed -$11M 32
2023
Q4
$11M Buy
+114,042
New +$11M 7.36% 5